Due to the unprecedented nature of the COVID-19 pandemic, anyone reporting an Adverse Event and/or a Product Complaint via phone, should you receive a network busy signal (ie: if all lines busy/engaged) please continue to try your call throughout the day. Alternatively, you may email your Adverse Event to firstname.lastname@example.org OR Product Complaint to email@example.com, OR medical information request to MedInfo@propharmagroup.com.
PARAMUS, N.J., Jan. 15, 2019 /PRNewswire/ — WG Critical Care (WGCC), A Pharmasphere company, has launched the first and only FDA approved Calcium Gluconate in Sodium Chloride Injection in a Ready-To-Use Bag. “In addition to addressing a chronic drug shortage of this product, I’m excited to add another unique product to our expanding portfolio,” says...Read More
PARAMUS, N.J., March 1, 2018 /PRNewswire/ — WG Critical Care launched the first and only generic ready-to-use Esmolol HCl in Water for Injection (WFI), 2500 mg/250 mL (10 mg/mL) and Double Strength 2000 mg/100 mL (20 mg/mL). Esmolol is a cardiovascular agent indicated for rapid control of ventricular rate in patients with atrial fibrillation or...Read More
PARAMUS, N.J., Oct. 11, 2016 /PRNewswire/ — (WGCC), a wholly owned subsidiary of PharmaSphere, Inc., announced today that it has launched the first and only 400 mcg/4 mL and 1000 mcg/10 mL multi-dose vials. Dexmedetomidine HCl Injection is currently sold as a 2 mL vial by multiple manufacturers. Dexmedetomidine is also available in ready to...Read More
For More Information, Contact: Karen Pressman Digital Jam 917-650-2159 Karen@digital-jam.com Paramus, NJ, April 2, 2015 The Animal Health Division of WG Critical Care, LLC, a fully integrated pharmaceutical company, announced today that QUARTERMASTER® Suspension (penicillin-dihydrostreptomycin in oil), FDA approved for intramammary use to reduce the frequency of existing infection and to prevent new infections...Read More
For More Information, Contact: Michele Scrofani, Vice President HQ Specialty Pharma, LLC 201.857.8290 Paramus, NJ, April 15, 2014 HQ Specialty Pharma and its collaborating partner, WelGrace Research Group, have received tentative approval on its 505(b)(2) application for Esmolol Hydrochloride Premixed Injection, which references Brevibloc® Injection. The product will be available in two...Read More
Penicillin G Potassium for Injection, USP WG Critical Care has launched Penicillin G Potassium for Injection, USP in 20 MM unit and 5 MM Unit vials. Product is currently available at wholesalers. Read More
Ceftazidime for Injection, USP WG Critical Care provides Ceftazidime for Injection, USP in 1 and 2 gram vials, as well as a 6 gram Pharmacy Bulk Pack (PBP) as part of its expanding line of essential injectable products. Product is currently available at wholesalers. Read More